financetom
Business
financetom
/
Business
/
QUOTES-Investors react to Trump announcement of auto tariffs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
QUOTES-Investors react to Trump announcement of auto tariffs
Mar 26, 2025 6:16 PM

(Adds second and third investor comments)

March 26 (Reuters) - U.S. President Donald Trump said

late on Wednesday that the United States will effectively charge

a 25% tariff on all cars not made in the country and that the

new duties on cars and light trucks imported into the United

States will be permanent.

Shares of General Motors ( GM ) and Ford fell in

extended trade after Trump's announcement, while shares of Tesla

initially fell then bounced after he said the tariffs

could be neutral for Tesla.

COMMENTS:

CHUCK CARLSON, CHIEF EXECUTIVE OFFICER, HORIZON INVESTMENT

SERVICES, HAMMOND, INDIANA

"I've been kind of suspect on all the tariff talks in terms

of what is going to last, what is a negotiation, what is going

to be pulled at the last minute. My initial reaction was this

tariff might have some legs."

"There's probably going to be some exemptions or

modifications for some of the U.S. automakers... I could see the

U.S. automakers getting some exemptions based on their supply

chains. But I think he may want to see how this works out as

opposed to stopping it in two or three days. That's my initial

reaction, that this particular tariff might have legs in terms

of its longevity."

PRASHANT NEWNAHA, SENIOR ASIA-PACIFIC RATES STRATEGIST, TD

SECURITIES, SINGAPORE

"These auto tariffs are likely on top of other tariffs on

steel, aluminum, copper and the impending reciprocal tariffs to

be announced on 2nd April. It's hard not to interpret this as

anything but a cue for higher prices and lower growth with a

soft landing becoming more complicated. Countries most exposed

to the new auto tariffs are Slovakia, Mexico, South Korea and

Japan. Keep an eye on stocks of car makers, the Korean won and

Mexican peso."

KYLE RODDA, SENIOR FINANCIAL MARKET ANALYST,

CAPITAL.COM, MELBOURNE

"There are a lot of layers here. However, I think the big

concern is that not only will these tariffs be disruptive and

economically harmful, but it indicates that the Trump

administration's shake-up of global trade won't necessarily end

with next week's April 2nd announcement of reciprocal tariffs,

as previously hoped. This potentially drags out trade

uncertainty even longer and raises the question of how radical a

change to the global trade order is Trump trying to bring

about."

(Compiled by the Global Finance & Markets Breaking News team;

Editing by Jamie Freed)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Goldman Sachs Raises CEO David Solomon's Compensation to $39 Million in 2024
Goldman Sachs Raises CEO David Solomon's Compensation to $39 Million in 2024
Jan 17, 2025
10:23 AM EST, 01/17/2025 (MT Newswires) -- Goldman Sachs Group ( GS ) said in a regulatory filing Friday its board has approved to increase Chief Executive David Solomon's total annual compensation to $39 million in 2024 from $31 million in 2023. Solomon and Chief Operating Officer John Waldron were also given restricted stock units valued at $80 million each...
Bausch Health Notes Xifaxan 550 mg Selected For Medicare 2nd Round Negotiations
Bausch Health Notes Xifaxan 550 mg Selected For Medicare 2nd Round Negotiations
Jan 17, 2025
10:27 AM EST, 01/17/2025 (MT Newswires) -- Bausch Health Companies ( BHC ) , down near 1% at last look, on Friday said the Centers for Medicare and Medicaid Services (CMS) has selected Xifaxan (rifaximin) 550 mg tablets for the second round of negotiation as part of the Inflation Reduction Act. We look forward to engaging in open and transparent...
Zai Lab's Schizophrenia Drug Application Accepted by Chinese Regulator; Shares Rise
Zai Lab's Schizophrenia Drug Application Accepted by Chinese Regulator; Shares Rise
Jan 17, 2025
10:20 AM EST, 01/17/2025 (MT Newswires) -- Zai Lab ( ZLAB ) said Friday that its new drug application for KarXT to treat adult patients with schizophrenia was accepted by China's National Medical Products Administration. The application is backed by results from a phase 1 China pharmacokinetics study, the phase 3 China study and data from global Emergent clinical programs,...
LPL Financial to Pay $18 Million Civil Penalty to Settle US SEC Anti-Money Laundering Charges
LPL Financial to Pay $18 Million Civil Penalty to Settle US SEC Anti-Money Laundering Charges
Jan 17, 2025
10:27 AM EST, 01/17/2025 (MT Newswires) -- LPL Financial ( LPLA ) has agreed to pay an $18 million civil penalty to the US Securities and Exchange Commission to settle charges of anti-money laundering violations, the agency said Friday. In order to resolve the SEC's charges, the financial services company will also implement improvements to its anti-money laundering policies and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved